GlassScriptPhysician profile
Melody G Harrison
NPI 1306012026
$1,356.47
in general payments reported to CMS, 2019-2025
20 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $325 · 2022: $253 · 2023: $319 · 2024: $158 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559 · Education: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.90 |
| Education | $219.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $247.85 | 2021-2023 | Wegovy |
| Aspira Women'S Health INC | $219.40 | 2021-2023 | Ova1 |
| Astellas Pharma US INC | $199.98 | 2024-2025 | |
| Abbvie INC. | $124.93 | 2021-2023 | |
| Exeltis, USA INC. | $81.63 | 2021-2025 | Slynd |
| Sage Therapeutics, LLC | $76.36 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $66.65 | 2021-2025 | |
| Axonics, INC. | $64.91 | 2023 | Axonics, Bulkamid |
| Lilly USA, LLC | $38.74 | 2024-2025 | Zepbound |
| Daiichi Sankyo INC. | $36.67 | 2021 | |
| Exact Sciences Corporation | $34.66 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $24.10 | 2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $23.79 | 2021 | |
| Pfizer INC. | $19.75 | 2025 | |
| Sumitomo Pharma America, INC. | $19.27 | 2023 | Myfembree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $17.09 | 2023 | Floseal |
| Boston Scientific Corporation | $16.90 | 2021 | |
| Supernus Pharmaceuticals, INC. | $16.38 | 2025 | Qelbree |
| Vertex Pharmaceuticals Incorporated | $15.44 | 2025 | |
| Evofem Biosciences, INC. | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.